Citations

Clear

6 citation(s) found for "Brenner, Michael".

Tackling the Minority Tax: A Roadmap to Redistributing Engagement in Diversity, Equity, and Inclusion Initiatives
Faucett, Erynne A. , Brenner, Michael , Thompson, Dana M. , Flanary, Valerie A.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | April 5, 2022 | Volume: 166 | Issue: 6 | Pages: 1174-1181

10.1177/01945998221091696 | PMID 35380882 Get It

Academic medical centers striving to implement diversity, equity, and inclusion (DEI) and antiracism initiatives often ask faculty to volunteer substantial time to committee work, recruitment, mentoring, community, and administrative responsibilities. These requests are not in lieu of current workload and seldom count toward scholarship; the service may go unrecognized, unrewarded, and uncompensated. URiM faculty (underrepresented in medicine) providing such service thus pay a minority tax when precious time is syphoned away from career‐advancing activities and personal growth. The resulting strain on available resources has social, psychological, and monetary ramifications that can undermine the long‐term objectives of DEI initiatives. We examine the facets of the minority tax, consider the current state of diversity, and present a roadmap to redistribute, reform, and reduce URiM taxation through shared engagement in DEI initiatives. Key interventions include ascribing value to DEI efforts, implementing evidence‐based policies to reduce bias, and promoting mentorship, sponsorship, and allyship.
Patient Safety/Quality Improvement Primer, Part II: Prevention of Harm Through Root Cause Analysis and Action (RCA2)
Balakrishnan, Karthik , Brenner, Michael , Gosbee, John, Schmalbach, Cecelia E. , Balakrishnan, Karthik

Mayo Clinic

Otolaryngology–Head and Neck Surgery | October 1, 2019 | Volume: 161 | Issue: 6 | Pages: 911-921

10.1177/0194599819878683 | PMID 31570058 Get It

With increasing emphasis on patient safety/quality improvement, health care systems are mirroring industry in the implementation of root cause analysis (RCA) for the identification and mitigation of errors. RCA uses a team approach with emphasis on the system, as opposed to the individual, to accrue empirical data on what happened and why. While many otolaryngologists have a broad understanding of RCA, practical experience is often lacking. Part II of this patient safety/quality improvement primer investigates the manner in which RCA is utilized in the prevention of medical errors. Attention is given to identifying system errors, recording adverse events, and determining which events warrant RCA. The primer outlines steps necessary to conduct an effective RCA, with emphasis placed on actions that arise from the RCA process through the root cause analysis and action (or RCA2) rubric. In addition, the article provides strategies for the implementation of RCA into clinical practice and medical education.
Impact of a Formal Patient Safety and Quality Improvement Curriculum: A Prospective, Controlled Trial
Jamal, Nausheen, Brenner, Michael , Balakrishnan, Karthik , Bent, John P. , Bowe, Sarah N. , Balakrishnan, Karthik

Mayo Clinic

The Laryngoscope | November 16, 2018 | Volume: 129 | Issue: 5 | Pages: 1100-1106

10.1002/lary.27527 | PMID 30443935 Get It

ObjectiveTo assess the impact of implementing a dedicated Patient Safety and Quality Improvement (PSQI) curriculum for otolaryngology residents.MethodsResidents in two otolaryngology residency programs were recruited to participate in the study. Residents at institution A (intervention group) participated in a formal, newly developed, year‐long PSQI curriculum. Residents at institution B (control group) participated in traditional, morbidity, and mortality conference‐based PSQI education, with no formal curriculum in place. Curriculum participants completed anonymous surveys to assess learner satisfaction. Validated instruments were administered to assess for changes in resident confidence in the ability to develop PSQI projects, their attitudes toward patient safety, and PSQI‐related knowledge. The number and quality of PSQI‐related resident projects were also assessed.ResultsSurvey responses demonstrated excellent learner satisfaction with the curriculum. Based on validated instrument‐based responses, both programs demonstrated similar confidence scores (P = 0.05), safety attitudes (P = 0.82), and PSQI knowledge (P = 0.29) at the beginning of the year. The residents of institution A demonstrated significant improvement in confidence (P = 0.00009) and knowledge (P = 0.0006) after completing the curriculum, with no improvement noted for residents at institution B in either confidence (P = 0.06) or knowledge (P = 0.79). Neither program demonstrated improvement in attitudes toward patient safety at the end of the year‐long curriculum.ConclusionImplementing a formal curriculum dedicated to PSQI led to an improvement in PSQI‐related project development confidence and PSQI knowledge. Attitudes toward safety did not improve over the course of a year. Longer‐term studies involving multiple institutions and other interventions are needed to evaluate the impact and duration of changes that occur.Level of Evidence1b Laryngoscope, 129:1100–1106, 2019
Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies
Assefnia, Shahin, Dakshanamurthy, Sivanesan , Auvil, Jaime M. Guidry , Hampel, Constanze, Anastasiadis, Panos Z. , Üren, Aykut , Foley, David , Brown, Milton L. , Shapiro, Lawrence , Brenner, Michael B. , Haigh, David, Byers, Stephen W. , Kallakury, Bhaskar

Mayo Clinic

Oncotarget | September 16, 2015 | Volume: 5 | Issue: 6 | Pages: 1458-1474

10.18632/oncotarget.1538 | PMID 24681547 Get It

Abstract A045: Cadherin-11, a common therapeutic target in poor prognosis malignancies and rheumatoid arthritis
Assefnia, Shahin, Dakshanamurthy, Sivanesan , Auvil, Jaime M. Guidry , Hampel, Constanze, Anastasiadis, Panos Z. , Foley, David , Brown, Milton L. , Shapiro, Lawrence , Brenner, Michael B. , Haigh, David, Byers, Stephen W. , Kallakury, Bhaskar , Üren, Aykut

Mayo Clinic

Molecular Cancer Research | May 4, 2015 | Volume: 11 | Issue: 10_Supplement | Pages: A045-A045

10.1158/1557-3125.advbc-a045 Get It

Abstract Rational: Poor prognosis epithelial-derived cancers often exhibit morphologic and molecular changes characteristic of an epithelial to mesenchymal transition (EMT). EMT markers are predominantly found in tumors with a basal-like phenotype. Increased expression of the mesenchymal cadherins N-cadherin and/or Cadherin-11 (CDH11) and decreased E-cadherin, have been associated with both EMT and tumor progression. Importantly, CDH11 is a therapeutic target in rheumatoid arthritis (RA), an inflammatory disease with properties often compared with cancer. As CDH11 antibody based therapeutics are in clinical trials for RA and we recently showed that the arthritis drug celecoxib has the structural potential to bind CDH11, there is a strong possibility that, if CDH11can be shown to drive malignant progression rather than simply be associated with it, therapeutic options may be rapidly developed. Results: We show that CDH11 is increased early in breast cancer and ductal carcinoma in-situ. CDH11 knockdown and antibodies effective in RA slowed the growth of basal-like breast tumors. CDH11 attenuation decreased proliferation and colony formation of breast, glioblastoma and prostate cancer cells. The arthritis drug celecoxib, which has characteristics consistent with CDH11 binding, an analogue without COX-2 inhibitory activity and other molecules that target CDH11, preferentially affect CDH11 positive cancer cells. Conclusion: Our work demonstrates that cadherin-11 is important for malignant progression, is a therapeutic target in several aggressive tumors and introduces an antibody, novel small molecules and an approved arthritis drug that inhibit its function with potential for rapid clinical translation. Citation Format: Shahin Assefnia, Sivanesan Dakshanamurthy, Jaime M. Guidry Auvil, Constanze Hampel, Panos Anastasiadis, Bhaskar Kallakury, Aykut Uren, David W. Foley, Milton Brown, Lawrence Shapiro, Michael Brenner, David Haigh, Stephen W. Byers. Cadherin-11, a common therapeutic target in poor prognosis malignancies and rheumatoid arthritis. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications; Oct 3-6, 2013; San Diego, CA. Philadelphia (PA): AACR; Mol Cancer Res 2013;11(10 Suppl):Abstract nr A045.
Soft matrix is a natural stimulator for cellular invasiveness
Gu, Zhizhan , Liu, Fei , Tonkova, Elina A., Lee, Soo Young , Tschumperlin, Daniel J. , Brenner, Michael B.

Mayo Clinic

Molecular Biology of the Cell | December 12, 2013 | Volume: 25 | Issue: 4 | Pages: 457-469

10.1091/mbc.e13-05-0260 | PMID 24336521 Get It

Directional mesenchymal cell invasion in vivo is understood to be a stimulated event and to be regulated by cytokines, chemokines, and types of extracellular matrix (ECM). Instead, by focusing on the cellular response to ECM stiffness, we found that soft ECM (low stiffness) itself is sufficient to prevent stable cell-to-cell adherens junction formation, up-regulate matrix metalloproteinase (MMP) secretion, promote MMP activity, and induce invadosome-like protrusion (ILP) formation. Consistently, similar ILP formation was also detected in a three-dimensional directional invasion assay in soft matrix. Primary human fibroblasts spontaneously form ILPs in a very narrow range of ECM stiffness (0.1–0.4 kPa), and such ILP formation is Src family kinase dependent. In contrast, spontaneous ILP formation in malignant cancer cells and fibrosarcoma cells occurs across a much wider range of ECM stiffness, and these tumor cell ILPs are also more prominent at lower stiffness. These findings suggest that ECM softness is a natural stimulator for cellular invasiveness.